On-table Renal Perfusion Evaluation Renal Artery Stenosis or Obstruction
NCT ID: NCT03530748
Last Updated: 2020-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2018-04-09
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Explore the clinical benefits of this application during procedure to help the physician to determine the procedure endpoint.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Transcatheter Aortic Valve Replacement Using Echo Only With Echo Combined With X Ray for Patients With Aortic Stenosis
NCT07317804
A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis
NCT06136429
Real-World Prospective Parallel Controlled Study on Endovascular Therapy for Improving Perfusion and Remodeling of TBAD
NCT07022145
Study of Transcatheter Aortic Valve Replacement With A² Flex and Commissural Alignment Technology in Severe Aortic Stenosis
NCT06721676
Endovascular Aortic Repair for Aortic Dissection
NCT01505309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aortic dissection represents a common cardiovascular disease and it is responsible for the most commonly encountered pathologies in aortic emergency. Renal dysfunction is a common complication associated with aortic dissection, with resultant high mortality rate. The antegrade propagation of the dissection from the proximal aorta to the level of renal arteries and the intervention during surgery may both increase the risk of renal malperfusion; thus, it is important to assess renal function for pre- and post-operative evaluation and guidance for treatment. This can be achieved through perfusion imaging.
Presently, C-arm Cone Beam Computed Tomography (CBCT) perfusion is well established, in particular, in the diagnostic assessment of acute stroke and cerebral ischemia. The main novelty of our study lies in the fact that intra-procedural renal perfusion assessed for the first time semiquantitatively by Syngo Dyna Parenchymal Blood Volume(PBV) software, discriminate patients who will benefit from the intervention procedure.
In conclusion, our study suggests that a routine assessment of pre, and post-stenting renal perfusion could help to identify patients at higher risk of no improvement or even worsening of renal function after stenting and, perhaps, more aggressive medical therapy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Renal Artery Stenosis
Patients with simple renal artery stenosis or aortic dissection with renal artery obstruction
Endovascular therapy and Imaging Acquisition
1. Endovascular repair for renal artery stenosis;
2. Parenchymal Blood Volume(PBV) acquisition and analysis for target kidney
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endovascular therapy and Imaging Acquisition
1. Endovascular repair for renal artery stenosis;
2. Parenchymal Blood Volume(PBV) acquisition and analysis for target kidney
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Target kidney remains functional (GFR determined);
* The length of target kidney is \>8cm;
* Resistance index tested by doppler ultrasonography \<0.8;
* Comply with the protocol
Exclusion Criteria
* Pregnancy or lactation;
* History of renal artery surgery;
* Allergy of contrast agent;
* Other known reason nonischemic kidney disease
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhenyu Shi
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhenyu Shi, PhD
Role: PRINCIPAL_INVESTIGATOR
Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhenyu Shi, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2017-084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.